GRDN Guardian Pharmacy Services Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: GRDN
  4. Earnings
?
Relative Growth: Rel. Growth: 71
Relative Strength: Rel. Strength: 83
Relative Valuation: Rel. Valuation: 60
Relative Profitability: Rel. Profitability: 79

EPS in 2026 (TTM): $1.05

Last Report Period Date: Jun 30, 2026

According to the most recent financial data from June 2026, the EPS for the trailing twelve months is $1.05. Guardian Pharmacy Services's EPS for 2025 amounted to $0.79, marking an increase from -$1.77 in 2024. During the quarterly period ending on Jun 30, 2026, GRDN's EPS stood at $0.35.

GRDN earnings history

Historical annual and quarterly earnings per share (EPS) data for Guardian Pharmacy Services
EPS (TTM)
$1.05
EPS Growth YoY (Quarterly)
133.3%
EPS (Quarterly)
$0.35
EPS Growth (Quarterly)
66.7%

Guardian Pharmacy Services had an annual EPS of $0.79, indicating an increase of 144.6% from -$1.77 in 2024. The quarterly per-share earnings for the period ending Jun 30, 2026, was $0.35, indicating a 133.3% increase from the same quarter last year. GRDN's 12-month EPS stands at $1.05 as of June 2026.

GRDN EPS vs price chart

GRDN EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
133.3%
EPS growth YoY
144.6%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
N/A

Guardian Pharmacy Services has registered an increase in EPS of 133.3% during the last 12 months (YoY, quarterly).

GRDN Earnings Waterfall

Breakdown of revenue, profit and net income for Guardian Pharmacy Services

GRDN Earnings vs Peers

What are the earnings of GRDN compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
CVS CVS Health Corp 22.36 -61.9% -24.8% -23.9%
COR Cencora Inc 23.1 5.5% -0.5% N/A
MCK Mckesson Corporation 23.5 49.1% 15.2% N/A
HSIC Henry Schein Inc 24.65 7.2% -5.9% 3.1%
CAH Cardinal Health Inc 30.44 12.2% 78.9% 28.3%
GRDN Guardian Pharmacy Services Inc. 41.2 144.6% N/A N/A
ACH Accendra Health Inc N/A -202.5% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.